Delflex Solution
Product Images NDC 46163-206

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Delflex (NDC 46163-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Medical Care De Mexico, S.a. De C.v., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Del06 0000 01)

FDA Label Image

Figure (Del06 0000 02)

FDA Label Image

Figure (Del06 0000 03)

FDA Label Image

Figure (Del06 0000 04)

FDA Label Image

Figure (Del06 0000 05)

FDA Label Image

Figure (Del06 0000 06)

FDA Label Image

Figure (Del06 0000 07)

FDA Label Image

Figure (Del06 0000 08)

FDA Label Image

Figure (Del06 0000 09)

FDA Label Image

Figure (Del06 0000 10)

FDA Label Image

Figure (Del06 0000 11)

FDA Label Image

Figure (Del06 0000 12)

FDA Label Image

Figure (Del06 0000 13)

FDA Label Image

Principal Display Panel – 1.5% Dextrose 3000 mL Bag Label (Del06 0000 14)

Principal Display Panel – 1.5% Dextrose 3000 mL Bag Label (Del06 0000 14)
This is a description for DELFLEX® Peritoneal Dialysis Solution with 1.5% Dextrose. It is a low magnesium and low calcium solution designed for intraperitoneal administration. The solution comes in a 3,000 mL container with a stay * safe® Exchange Set attached. Each 100 mL contains specific amounts of dextrose, sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and water for injection. It is essential to store the solution at 20°C-25°C until ready to use and only use if the solution is clear and the container is undamaged. Additional instructions for proper use and disposal are provided on the packaging. This product does not contain latex materials and should only be used under the direction of a physician. Made in Mexico.*
FDA Label Image

Principal Display Panel – 2.5% Dextrose 3000 mL Bag Label (Del06 0000 15)

Principal Display Panel – 2.5% Dextrose 3000 mL Bag Label (Del06 0000 15)
This is a description of a DELFLEX® Peritoneal Dialysis Solution with 2.5% Dextrose, containing low magnesium, low calcium, and sodium chloride among other components. It comes with a stay * safe® Exchange Set and must be stored at 20°C-25°C until use. The solution is sterile and non-pyrogenic, intended for intraperitoneal administration only and should be used under aseptic technique. It is recommended to discard any unused portion and follow the prescribing information for dosage. The product is latex-free and manufactured by Fresenius Medical Care in Mexico.*
FDA Label Image

Principal Display Panel – 4.25% Dextrose 3000 mL Bag Label (Del06 0000 16)

Principal Display Panel – 4.25% Dextrose 3000 mL Bag Label (Del06 0000 16)
This is a description of DELFLEX® Peritoneal Dialysis Solution with 4.25% Dextrose. It includes information about its composition, such as low magnesium, low calcium, and other components. The solution is intended for intraperitoneal administration and should be used with aseptic technique. The text also provides storage instructions, dosage recommendations, and highlights that the product does not contain latex materials. It is a single-dose container that is sterile and non-pyrogenic. The solution is manufactured by Fresenius Medical Care in Mexico.*
FDA Label Image

Principal Display Panel – 1.5% Dextrose 2000 mL Bag Label (Del06 0000 17)

Principal Display Panel – 1.5% Dextrose 2000 mL Bag Label (Del06 0000 17)
This is a description of a Peritoneal Dialysis Solution called DELFLEX®, with 1.5% DEXTROSE, designed for intraperitoneal administration only. It contains low magnesium and low calcium levels and comes with a stay * safe® Exchange Set. The solution is sterile, non-pyrogenic, and does not contain latex materials. It should be stored at a temperature between 20°C-25°C until ready to use. The solution is in a single-dose container and should be discarded if the solution is not clear or if the container is damaged. The text provides detailed information on the contents of the solution, recommended dosage, and handling instructions.*
FDA Label Image

Principal Display Panel – 1.5% Dextrose 2500 mL Bag Label (Del06 0000 18)

Principal Display Panel – 1.5% Dextrose 2500 mL Bag Label (Del06 0000 18)
This is a description of DELFLEX® Peritoneal Dialysis Solution with 1.5% Dextrose. It contains low magnesium and low calcium, with each 100 mL including Dextrose Hydrous, USP 15g, Sodium Chloride, USP 538 mg, Sodium Lactate 448 mg, Calcium Chloride, USP 18.4 mg, and Magnesium Chloride, USP 5.1mg. The solution is intended for intraperitoneal administration only and comes with a stay•safe® Exchange Set. It is sterile, non-pyrogenic, and should be stored at 20°C-25°C (68°F-77°F). The product does not contain latex materials and is recommended for single-dose use under the direction of a physician.*
FDA Label Image

Principal Display Panel – 2.5% Dextrose 2000 mL Bag Label (Del06 0000 19)

Principal Display Panel – 2.5% Dextrose 2000 mL Bag Label (Del06 0000 19)
This text appears to be a product description for a Peritoneal Dialysis Solution with 2.5% Dextrose, designed for intraperitoneal administration. It contains low magnesium and low calcium levels and comes with a stay * safe® Exchange Set. The solution is sterile, non-pyrogenic, and intended for single-dose use. It is important to store the product in specific temperature conditions until ready to use, following aseptic techniques during administration. The solution's components are listed, including approximate milliequivalents per liter. This product does not contain latex materials and is intended for use only under the direction of a physician.*
FDA Label Image

Principal Display Panel – 2.5% Dextrose 2500 mL Bag Label (Del06 0000 20)

Principal Display Panel – 2.5% Dextrose 2500 mL Bag Label (Del06 0000 20)
This text is a description of Delflex Peritoneal Dialysis Solution with 2.5% Dextrose, which is a low magnesium, low calcium solution used for peritoneal dialysis. It comes with a Stay-safe Exchange Set and is a single-dose container that is sterile and non-pyrogenic. The solution contains specific amounts of various components like Dextrose, Sodium Chloride, Sodium Lactate, Calcium Chloride, and Magnesium Chloride, among others. The product should be stored in specific temperature conditions and should only be used if the solution is clear and the container is undamaged. The recommended dosage is advised to be followed as per the prescribing information. Additionally, the product is latex-free.*
FDA Label Image

Principal Display Panel – 4.25% Dextrose 2000 mL Bag Label (Del06 0000 21)

Principal Display Panel – 4.25% Dextrose 2000 mL Bag Label (Del06 0000 21)
This is a description of DELFLEX® Peritoneal Dialysis Solution containing 4.25% dextrose with low magnesium and low calcium levels. It includes a stay * safe® Exchange Set and each 100 mL consists of various components such as dextrose, sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and water. The solution is for intraperitoneal use only and must be stored at specified temperatures. It is a single-dose sterile and non-pyrogenic container. The text also provides information on recommended dosage and precautions to follow while using the product.*
FDA Label Image

Principal Display Panel – 4.25% Dextrose 2500 mL Bag Label (Del06 0000 22)

Principal Display Panel – 4.25% Dextrose 2500 mL Bag Label (Del06 0000 22)
This is a description of DELFLEX® Peritoneal Dialysis Solution with 4.25% Dextrose. It contains low magnesium, low calcium, and is accompanied by a stay * safe® Exchange Set. The solution is intended for intraperitoneal administration only and comes in a sterile, non-pyrogenic single-dose container. Instructions on storage, usage, and dosage are provided along with safety precautions such as checking for clarity and container integrity before use. It does not contain latex materials and should be used under the guidance of a physician.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.